KCNT1 inhibitors and methods of use
The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a ne...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
06.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein. |
---|---|
Bibliography: | Application Number: AU20200267355 |